Matthew McKinney
Duke Cancer Institute
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Immune Cell Function and Interaction, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, T-cell and B-cell Immunology
Most-Cited Works
- → The genetic landscape of mutations in Burkitt lymphoma(2012)596 cited
- → The Genetic Basis of Hepatosplenic T-cell Lymphoma(2017)199 cited
- → Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2(2017)170 cited
- → GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo(2016)63 cited
- → Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study(2024)31 cited
- → Erythropoietin for oncology supportive care(2011)23 cited
- → Induction of Wilms' Tumor Protein (WT1)–Specific Antitumor Immunity Using a Truncated WT1-Expressing Adenovirus Vaccine(2009)15 cited
- → Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy(2021)13 cited
- → Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function(2011)11 cited
- → Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)(2024)4 cited